Depressive Disorder
Conditions
Interventions
There is no intervention. This is a prospective, quantitative observational study with a cohort design. The study will recruit 202 patients of both sexes who are using full-spectrum medical cannabis o
Sponsors
Universidade Federal de Santa Catarina
Instituto de Ensino e Pesquisa (IEP) Remederi
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adults aged 18 or older; of both sexes; residing in the state of Santa Catarina; with a medical diagnosis of anxiety disorder and/or depressive disorder according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5); regularly using full-spectrum medicinal cannabis oil prescribed by their attending physician; cognitively capable of understanding the study procedures and providing free and informed consent
Exclusion criteria
Exclusion criteria: Individuals with medical contraindications to the use of medicinal cannabis; unable to provide the necessary saliva sample; lacking the minimum clinical data required for analysis; or who refuse to participate in the research or sign the informed consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in anxiety and depressive symptoms measured by GAD-7 and PHQ-9 scores over time (baseline to follow-up up to 90 days) | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of adverse events associated with medical cannabis use, including sedation, mood changes, cognitive impairment, gastrointestinal symptoms, and other reported effects | — |
Countries
BR
Contacts
Public ContactAderbal Aguiar
Universidade Federal de Santa Catarina
Outcome results
None listed